Innospec (IOSP) Cost of Revenue (2010 - 2026)

Innospec has disclosed Cost of Revenue across 17 years of filings, most recently posting $329.7 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $329.7 million, up 4.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 2.03% YoY), and the FY2025 annual result was $1.3 billion, down 1.3% from the prior year.
• Cost of Revenue came in at $329.7 million for Q1 2026 at Innospec, roughly flat from $328.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $361.8 million in Q1 2023 to a low of $308.1 million in Q2 2024.
• The 5-year median for Cost of Revenue is $329.7 million (2026), against an average of $332.5 million.
• Across the five-year window, Cost of Revenue jumped 39.49% in 2022 and retreated 8.43% in 2023, its largest moves.
• Innospec's Cost of Revenue stood at $359.1 million in 2022, then slipped by 5.6% to $339.0 million in 2023, then decreased by 2.48% to $330.6 million in 2024, then dropped by 0.73% to $328.2 million in 2025, then increased by 0.46% to $329.7 million in 2026.
• The last three Cost of Revenue figures came in at $329.7 million (Q1 2026), $328.2 million (Q4 2025), and $325.2 million (Q3 2025), per Business Quant data.